Compared with non-CLBC patients, younger people with less aggressive characteristics such as lower histologic grade, smaller tumor size, none or limited lymph node metastasis, and positive ER or PR status, or negative HER-2 in CLBC cohorts were more likely to receive mastectomy, instead of BCS. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.